We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+4.4%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.57B
AUM Growth
+$128M
Cap. Flow
+$62.6M
Cap. Flow %
2.44%
Top 10 Hldgs %
25.2%
Holding
1,568
New
130
Increased
976
Reduced
425
Closed
36

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$4.92M
2
GILD icon
Gilead Sciences
GILD
+$4.9M
3
AGN
Allergan plc
AGN
+$4.71M
4
WBA
Walgreens Boots Alliance
WBA
+$4.69M
5
CELG
Celgene Corp
CELG
+$4.25M

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$7.22M
2
CBST
CUBIST PHARMACEUTICALS INC
CBST
+$6.44M
3
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$3.48M
4
RFMD
RF MICRO DEVICES INC
RFMD
+$3.03M
5
PG icon
Procter & Gamble
PG
+$2.89M

Sector Composition

Rank Sector Weight
1 Healthcare 34.98%
2 Technology 14.32%
3 Consumer Discretionary 7.2%
4 Communication Services 6.5%
5 Financials 6.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
1
Gilead Sciences
GILD
$162B
$120M 4.68%
1,226,722
+48,251
+4% +$4.9M
AMGN icon
2
Amgen
AMGN
$198B
$99.9M 3.89%
625,016
+31,268
+5% +$4.92M
BIIB icon
3
Biogen
BIIB
$29.2B
$81.5M 3.17%
192,997
+8,350
+5% +$3.29M
CELG
4
DELISTED
Celgene Corp
CELG
$76M 2.96%
659,140
+35,581
+6% +$4.25M
ABBV icon
5
AbbVie
ABBV
$448B
$72M 2.8%
1,229,243
+70,085
+6% +$4.23M
AAPL icon
6
Apple
AAPL
$4.79T
$64.6M 2.51%
2,077,448
-21,880
-1% -$661K
INTC icon
7
Intel
INTC
$516B
$35.7M 1.39%
1,142,468
+8,654
+0.8% +$292K
GOOG icon
8
Alphabet (Google) Class C
GOOG
$4.17T
$34.4M 1.34%
1,250,303
-16,165
-1% -$433K
JNJ icon
9
Johnson & Johnson
JNJ
$615B
$33.9M 1.32%
336,698
+14,815
+5% +$1.51M
MSFT icon
10
Microsoft
MSFT
$2.9T
$29.6M 1.15%
728,735
-15,473
-2% -$674K
ALXN
11
DELISTED
Alexion Pharmaceuticals
ALXN
$28.9M 1.12%
166,530
+11,436
+7% +$2.07M
REGN icon
12
Regeneron Pharmaceuticals
REGN
$68.3B
$28M 1.09%
61,961
+3,106
+5% +$1.32M
PFE icon
13
Pfizer
PFE
$141B
$25.3M 0.99%
767,455
+18,990
+3% +$604K
XOM icon
14
ExxonMobil
XOM
$640B
$24M 0.93%
282,623
-12,504
-4% -$1.11M
VRTX icon
15
Vertex Pharmaceuticals
VRTX
$120B
$23.5M 0.91%
199,169
+12,336
+7% +$1.48M
ILMN icon
16
Illumina
ILMN
$28.9B
$21.2M 0.83%
117,475
+6,494
+6% +$1.22M
AMZN icon
17
Amazon
AMZN
$2.63T
$21M 0.82%
1,130,520
+18,100
+2% +$318K
META icon
18
Meta Platforms (Facebook)
META
$1.59T
$20.9M 0.81%
254,100
+3,213
+1% +$252K
MRK icon
19
Merck
MRK
$315B
$19.7M 0.77%
360,044
+16,433
+5% +$930K
BMRN icon
20
BioMarin Pharmaceuticals
BMRN
$11.3B
$14.6M 0.57%
117,289
+12,349
+12% +$1.31M
TXN icon
21
Texas Instruments
TXN
$268B
$14.3M 0.56%
250,370
+5,401
+2% +$303K
AGN
22
DELISTED
Allergan plc
AGN
$13.9M 0.54%
46,548
+16,506
+55% +$4.71M
CMCSA icon
23
Comcast
CMCSA
$84B
$13.8M 0.54%
487,896
+2,898
+0.6% +$83.3K
CVX icon
24
Chevron
CVX
$384B
$13.7M 0.53%
130,758
-5,201
-4% -$555K
BMY icon
25
Bristol-Myers Squibb
BMY
$124B
$12.7M 0.49%
197,020
+10,746
+6% +$673K
1
2 3 4 5

Similar funds

MASUI
MIRAE ASSET SECURITIES (USA) INC. New York $2.72B AUM 36.56% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
MSL
Mackay Shields LLC New York $2.73B AUM 2.13% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
APSPRSPT
Arizona Public Safety Personnel Retirement System (PSPRS) Trust Phoenix, Arizona $2.72B AUM 6.25% 1-Year Est. Return
TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return

Profund Advisors's Q1 2015 Portfolio in Review

As of Q1 2015, Profund Advisors held 1,568 positions worth $2.57B, up 5.3% from $2.44B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Profund Advisors's Q1 2015 filing shows 130 new, 976 increased, 425 reduced and 36 closed positions. Its largest new stake was Qorvo: 54,378 shares worth $4.33M. The largest sale was Allergan Inc, an estimated $7.22M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Profund Advisors's largest Q1 2015 buy was Qorvo: 54,378 shares worth $4.33M.
  • Profund Advisors added most to Amgen in Q1 2015, an estimated $4.92M increase.
  • Profund Advisors's biggest Q1 2015 reduction was Procter & Gamble, cutting an estimated $2.89M.
  • Profund Advisors fully exited Allergan Inc in Q1 2015, selling an estimated $7.22M.
  • Profund Advisors's ten largest holdings make up 25% of its $2.57B portfolio in Q1 2015.
  • Profund Advisors opened 130 new positions and closed 36 in Q1 2015.
  • Profund Advisors's portfolio value rose 5.3% quarter-over-quarter to $2.57B.

Based on Profund Advisors's 13F filing for Q1 2015, filed 8 May 2015.